CMS Proposes Coverage With Study Participation For PET In Bone Metastasis
This article was originally published in The Gray Sheet
Executive Summary
CMS is proposing to cover positron emission tomography imaging for identification of bone metastasis in patients with a previously diagnosed solid tumor, but only as part of prospective clinical trials, the agency announced Nov. 30